Please assess the completion status of the following clinical trial:

Trial Title: Bilateral Transversus Abdominis Plane Block With or Without Magnesium

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists (ASA) rating I-III~* Age 18-75 years old~* Female~* Undergoing elective total abdominal hysterectomy (TAH) with or without uni/bilateral salpingo-oophorectomy (BSO) under general anesthesia with a Pfannenstiel incision~* Admitted to hospital postoperatively (inpatients)~* Competent to provide informed consent~Exclusion Criteria:~* Emergency TAH ± BSO~* ASA IV-V~* Allergy or sensitivity to study-related medications~* Taking any medications that are contraindicated for the use of any of our study drugs~* Midline incision~* Other regional anesthesia technique (e.g. epidural)~* Morbidly Obese (BMI \> 40)~* Incompetent to provide informed consent~* eGFR \< 50~* Impaired liver function (INR \> 1.5)~* Pre-existing chronic pain condition requiring chronic opioid use~* Significant co-existing cardiovascular disease

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Magnesium (Type: EXPERIMENTAL): Participants in this arm will receive magnesium sulfate + ropivacaine in their bilateral transversus abdominis plane blocks
- Non-magnesium (Type: ACTIVE_COMPARATOR): Participants in this arm will receive saline + ropivacaine in their bilateral transversus abdominis plane blocks

Based on this trial design, predict the completion outcome and termination type (if applicable).